13F Holdings
中文EN

HIMS Hims & Hers Health, Inc.

Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1773751 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY29.8%
TTM net income YoY-242.6%
TTM EPS YoY-256.6%
Revenue 3-yr CAGR53.6%
Net income 3-yr CAGR—

Margins

Gross margin63.8%
Operating margin-8.1%
Net margin-6.7%
FCF margin0.3%
EBITDA margin-4.3%

Returns

ROE-40.8%
ROA-6.6%
ROIC (approx.)—
Asset turnover0.99x

Leverage & solvency

Liabilities / assets90.0%
Debt / equity0.00x
Current ratio0.92x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.94x
Accruals ratio-12.8%
Payout ratio—
Capex / revenue6.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.35B$1.48B$872.00M$526.92M$271.88M
Cost of revenue$614.26M$303.38M$157.05M$118.19M$67.38M
Gross profit$1.73B$1.17B$714.95M$408.72M$204.49M
SG&A expense$272.72M$167.77M$129.88M$98.19M$113.66M
Operating income$105.61M$61.90M-$29.45M-$68.70M-$115.04M
Interest expense————$0
Pretax income$123.92M$71.71M-$21.57M-$65.71M-$110.80M
Income tax-$4.44M-$54.33M$1.98M-$31,000-$3.14M
Net income$128.37M$126.04M-$23.55M-$65.68M-$107.66M
EBITDA$160.12M$78.99M-$19.94M-$61.22M-$110.97M
EPS (basic)0.570.58-0.11-0.32-0.58
EPS (diluted)0.510.53-0.11-0.32-0.58
Weighted avg. shares (diluted)258.23M236.81M209.34M204.52M186.78M
Balance sheet
Cash & equivalents$228.62M$221.44M$96.66M$47.63M$72.64M
Short-term investments$348.88M$79.67M$124.32M$132.85M$175.49M
Receivables$32.15M$6.10M$6.70M$3.90M$4.10M
Inventory$80.13M$64.43M$22.46M$21.56M$13.56M
Current assets$767.64M$395.83M$265.05M$216.59M$269.90M
PP&E, net———$3.00M$2.20M
Goodwill$278.32M$112.73M$110.88M$110.88M$110.88M
Intangibles$196.12M$43.41M$18.57M$21.84M$25.89M
Total assets$2.15B$707.54M$441.19M$366.34M$420.58M
Current liabilities$404.43M$221.37M$88.47M$47.94M$79.22M
Total liabilities$1.61B$230.82M$97.16M$54.60M$85.97M
Shareholders' equity$540.93M$476.72M$344.03M$311.74M$334.62M
Cash flow statement
Operating cash flow$300.01M$251.08M$73.48M-$26.53M-$34.41M
Capital expenditure$242.60M$52.80M$26.50M$7.20M—
Free cash flow$57.41M$198.28M$46.98M-$33.73M—
Investing cash flow-$1.02B-$19.05M-$12.11M$34.70M-$156.27M
Financing cash flow$729.62M-$107.84M-$11.47M-$33.13M$235.04M
Depreciation & amortization$54.50M$17.09M$9.52M$7.47M$4.08M
Stock-based compensation$135.24M$92.32M$66.08M$42.82M$67.21M
Share buybacks$89.96M$83.04M$2.00M$0$0

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.